Search research articles
Contact Us
Filters
Showing results (41-50 of 73) with videos related to
Page
of 8
Sort By:
Journal of Medicinal Chemistry
|
August 1, 1978
Potential antitumor agents. Synthesis, reactivity, and cytoxicity of alpha-methylene carbonyl compounds
J M Cassady, S R Byrn, I K Stamos, et al.
Journal of Natural Products
|
March 1, 1992
Isolation of potential cancer chemopreventive agents from Eriodictyon californicum
Y L Liu, D K Ho, J M Cassady, et al.
Biochemistry
|
November 20, 1990
Metabolic activation of 2-substituted derivatives of myristic acid to form potent inhibitors of myristoyl CoA:protein N-myristoyltransferase
L A Paige, G Q Zheng, S A DeFrees, et al.
Journal of Natural Products
|
March 1, 1987
New xanthones from Psorospermum febrifugum
A M Habib, K S Reddy, T G McCloud, et al.
Journal of Medicinal Chemistry
|
November 1, 1977
Ergot alkaloids. Synthesis of 6-alkyl-8-ergolenes and 6-methyl-8-aminoergolines as potential prolactin inhibitors
A M Crider, J M Robinson, H G Floss, et al.
Life Sciences
|
January 1, 1988
Pyrimidine nucleosides enhance the efficacy of inhibitors of pyrimidine biosynthesis in cultured hepatocellular carcinoma cells
L B Jacobsen, J E Putnam, D P Sawick, et al.
Journal of Medicinal Chemistry
|
August 1, 1989
S-(2-oxopentadecyl)-CoA, a nonhydrolyzable analogue of myristoyl-CoA, is a potent inhibitor of myristoyl-CoA:protein N-myristoyltransferase
L A Paige, G Q Zheng, S A DeFrees, et al.
The Journal of Biological Chemistry
|
April 25, 1993
Reversible palmitoylation of the protein-tyrosine kinase p56lck
L A Paige, M J Nadler, M L Harrison, et al.
Journal of Medicinal Chemistry
|
March 1, 1974
Ergot alkaloids. Ergolines and related compounds as inhibitors of prolactin release
J M Cassady, G S Li, E B Spitzner, et al.
Biochemistry
|
September 7, 1993
Treatment of T cells with 2-hydroxymyristic acid inhibits the myristoylation and alters the stability of p56lck
M J Nadler, M L Harrison, C L Ashendel, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 73) with videos related to
Sort By:
Page
of 8
Journal of Medicinal Chemistry
|
August 1, 1978
Potential antitumor agents. Synthesis, reactivity, and cytoxicity of alpha-methylene carbonyl compounds
J M Cassady, S R Byrn, I K Stamos, et al.
Journal of Natural Products
|
March 1, 1992
Isolation of potential cancer chemopreventive agents from Eriodictyon californicum
Y L Liu, D K Ho, J M Cassady, et al.
Biochemistry
|
November 20, 1990
Metabolic activation of 2-substituted derivatives of myristic acid to form potent inhibitors of myristoyl CoA:protein N-myristoyltransferase
L A Paige, G Q Zheng, S A DeFrees, et al.
Journal of Natural Products
|
March 1, 1987
New xanthones from Psorospermum febrifugum
A M Habib, K S Reddy, T G McCloud, et al.
Journal of Medicinal Chemistry
|
November 1, 1977
Ergot alkaloids. Synthesis of 6-alkyl-8-ergolenes and 6-methyl-8-aminoergolines as potential prolactin inhibitors
A M Crider, J M Robinson, H G Floss, et al.
Life Sciences
|
January 1, 1988
Pyrimidine nucleosides enhance the efficacy of inhibitors of pyrimidine biosynthesis in cultured hepatocellular carcinoma cells
L B Jacobsen, J E Putnam, D P Sawick, et al.
Journal of Medicinal Chemistry
|
August 1, 1989
S-(2-oxopentadecyl)-CoA, a nonhydrolyzable analogue of myristoyl-CoA, is a potent inhibitor of myristoyl-CoA:protein N-myristoyltransferase
L A Paige, G Q Zheng, S A DeFrees, et al.
The Journal of Biological Chemistry
|
April 25, 1993
Reversible palmitoylation of the protein-tyrosine kinase p56lck
L A Paige, M J Nadler, M L Harrison, et al.
Journal of Medicinal Chemistry
|
March 1, 1974
Ergot alkaloids. Ergolines and related compounds as inhibitors of prolactin release
J M Cassady, G S Li, E B Spitzner, et al.
Biochemistry
|
September 7, 1993
Treatment of T cells with 2-hydroxymyristic acid inhibits the myristoylation and alters the stability of p56lck
M J Nadler, M L Harrison, C L Ashendel, et al.
Page
of 8